Drug that stops cancer cells hiding and a breakthrough pill for pancreatic cancer among highlights from Asco conference – but there were also notes of caution ...

In this free webinar, oncology experts will discuss what ASCO 2026 data could mean for cancer clinical trials and patient ...

These people shape everything from treatment availability to insurance plans and real-world results for patients.

ASCO is the preeminent cancer conference, bringing every oncology stakeholder to Chicago for a weekend of breakthrough presentations, pertinent health discussions and a bevy of brand activations.

Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...

Earlier this year, Daiichi Sankyo Global Head of Oncology Ken Keller told pharmaphorum about the company’s big year, with ...

Chinmay Jani, M.D., Sylvester chief fellow in hematology and oncology, will present his team’s ongoing phase I clinical trial at the 2026 ASCO conference. The study looks at escalating doses of a drug ...

RLTs were a hot topic at ASCO 2026, but experts note that certain limitations must be addressed to facilitate their widespread use in cancer care.

Add Yahoo as a preferred source to see more of our stories on Google. Clinical Trials Arena covers some of the highlights in blood cancer from ASCO 2026. Credit: inspiring.team / Shutterstock.com.

Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.

A two-day scientific programme brings together the UAE’s leading oncology experts to discuss the latest advancements from ...

Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.